OpenEvidence — the "ChatGPT for doctors" — just raised $200 million at a $6 billion valuation, a move that underscores how rapidly AI adoption in healthcare is accelerating. Trained on trusted journals like The New England Journal of Medicine and JAMA, this specialist platform handles around 15 million clinical consults a month and is free for verified clinicians via an ad‑supported model. Investors are betting big on niche healthcare AI—but what does that mean for you?

Quick facts